Skip to main content

Advertisement

Log in

Echocardiography in the Assessment of Patients with Rheumatologic Diseases

  • Echocardiography (JM Gardin, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Cardiovascular disease is an important extra-articular manifestation of rheumatologic diseases leading to considerable mortality and morbidity. Echocardiography emerges as a useful non-invasive technique for the screening and evaluation of cardiac involvement in these patients. With the technological advancement in echocardiographic techniques, we have gained a greater appreciation of the prevalence and nature of the cardiac involvement in these patients, as detection of subclinical disease is increasingly feasible. This review discusses cardiac involvement in patients with rheumatoid arthritis, systemic lupus erythematosus, anti-phospholipid antibody syndrome, systemic sclerosis and ankylosing spondylitis, and the role of different echocardiographic modalities in their evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Prasad M et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015;12(3):168–76. A recent review on the cardiovascular manifestations in patients with rheumatic diseases, their underlying pathophysiology and management strategies.

    Article  PubMed  Google Scholar 

  2. Hollan I et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12(10):1004–15.

    Article  CAS  PubMed  Google Scholar 

  3. Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006;45 Suppl 4:iv4–7.

    Google Scholar 

  4. Aslam F et al. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken). 2013;65(4):534–43.

    Article  Google Scholar 

  5. Faccini, A., J.C. Kaski, and P.G. Camici, Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. Eur Heart J, 2016. This recent paper reviewed coronary microvascular dysfunction (CMD) in chronic inflammatory rheumatoid diseases and the authors proposed a diagnostic algorithm which involves non-invasive imaging for the identification of CMD in these patients.

  6. Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol. 1998;17(5):369–77.

    Article  CAS  PubMed  Google Scholar 

  7. Roldan CA et al. Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates. Am J Cardiol. 2007;100(3):496–502.

    Article  PubMed  Google Scholar 

  8. Dweik RA et al. An official American Thoracic Society Statement: pulmonary hypertension phenotypes. Am J Respir Crit Care Med. 2014;189(3):345–55.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wislowska M et al. Systolic and diastolic heart function in SLE patients. Rheumatol Int. 2009;29(12):1469–76.

    Article  PubMed  Google Scholar 

  10. Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40(1):51–60.

    Article  PubMed  Google Scholar 

  11. Leal GN et al. Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography. Lupus. 2015;24(6):613–20.

    Article  CAS  PubMed  Google Scholar 

  12. Shazzad MN et al. Echocardiographic assessment of cardiac involvement in systemic lupus erythematosus patients. Mymensingh Med J. 2013;22(4):736–41.

    CAS  PubMed  Google Scholar 

  13. Denas G et al. Antiphospholipid syndrome and the heart: a case series and literature review. Autoimmun Rev. 2015;14(3):214–22. A recent comprehensive review on antiphospholipid antibody syndrome.

    Article  PubMed  Google Scholar 

  14. Taraborelli M, Andreoli L, Tincani A. Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a ‘systemic disease’. Best Pract Res Clin Rheumatol. 2012;26(1):79–90.

    Article  CAS  PubMed  Google Scholar 

  15. Erdogan D et al. Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study. Stroke. 2005;36(3):592–6.

    Article  PubMed  Google Scholar 

  16. Lambova S. Cardiac manifestations in systemic sclerosis. World J Cardiol. 2014;6(9):993–1005.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford). 2009;48 Suppl 3:iii45–8.

    Google Scholar 

  18. Ciurzynski M et al. Assessment of left and right ventricular diastolic function in patients with systemic sclerosis. Kardiol Pol. 2008;66(3):269–76. discussion 277–8.

    PubMed  Google Scholar 

  19. Heslinga SC et al. Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(1):14–9.

    Article  PubMed  Google Scholar 

  20. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Transl Med. 2015;3(4):51.

    PubMed  PubMed Central  Google Scholar 

  21. Caliskan M et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis. 2008;196(1):306–12.

    Article  CAS  PubMed  Google Scholar 

  22. Roldan CA et al. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32(5):1397–404.

    Article  CAS  PubMed  Google Scholar 

  23. Turiel M et al. The role of echocardiographic techniques in connective tissue diseases. Autoimmun Rev. 2005;4(3):171–7.

    Article  PubMed  Google Scholar 

  24. Perez-Villa F et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum. 2005;53(3):460–7.

    Article  PubMed  Google Scholar 

  25. Ungprasert P et al. Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol. 2014;171(3):326–30.

    Article  PubMed  Google Scholar 

  26. Sen D, Gonzalez-Mayda M, Brasington Jr RD. Cardiovascular disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2014;40(1):27–49.

    Article  PubMed  Google Scholar 

  27. Corrao S et al. Rheumatoid arthritis affects left ventricular mass: systematic review and meta-analysis. Eur J Intern Med. 2015;26(4):259–67.

    Article  PubMed  Google Scholar 

  28. Myasoedova E et al. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum. 2013;65(7):1713–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Midtbo H et al. Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology (Oxford). 2015;54(3):511–9.

    Article  Google Scholar 

  30. Fatma E et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489–95.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Toutouzas K et al. Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis: hypothesis-generating insights from a cross-sectional study. Rheumatology (Oxford). 2013;52(1):76–80.

    Article  Google Scholar 

  32. Kakuta, K., et al., Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition. J Am Soc Echocardiogr, 2015. This recent paper described the prevalence of CMD in patients with rheumatologic diseases using stress Doppler echocardiography.

  33. Saghir MK et al. Exercise echocardiography in rheumatoid arthritis: a case-control study. J Am Soc Echocardiogr. 2009;22(11):1228–31.

    Article  PubMed  Google Scholar 

  34. Kakuta K et al. Detection of coronary artery disease using coronary flow velocity reserve by transthoracic Doppler echocardiography versus multidetector computed tomography coronary angiography: influence of calcium score. J Am Soc Echocardiogr. 2014;27(7):775–85.

    Article  PubMed  Google Scholar 

  35. Rigo F et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol. 2003;91(3):269–73.

    Article  PubMed  Google Scholar 

  36. Turiel M et al. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford). 2009;48(7):834–9.

    Article  CAS  Google Scholar 

  37. Vizzardi E et al. Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritis. J Investig Med. 2012;60(8):1204–8.

    Article  PubMed  Google Scholar 

  38. Bhatia GS et al. Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden? J Am Coll Cardiol. 2006;47(6):1169–74.

    Article  PubMed  Google Scholar 

  39. Sitia S et al. Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol. 2012;160(1):8–14.

    Article  PubMed  Google Scholar 

  40. Fine NM et al. Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography. Ann Rheum Dis. 2014;73(10):1833–9.

    Article  PubMed  Google Scholar 

  41. Baktir AO et al. Preclinical impairment of myocardial function in rheumatoid arthritis patients. Detection of myocardial strain by speckle tracking echocardiography. Herz. 2015;40(4):669–74.

    Article  CAS  PubMed  Google Scholar 

  42. Ikonomidis I et al. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra. Thromb Haemost. 2011;106(5):959–67.

    Article  CAS  PubMed  Google Scholar 

  43. Nicola PJ et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005;52(2):412–20.

    Article  PubMed  Google Scholar 

  44. Vizzardi, E., et al., Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors. Clin Exp Rheumatol, 2015.

  45. Corrao S et al. Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol. 2013;167(5):2031–8.

    Article  PubMed  Google Scholar 

  46. Anaya JM. Severe rheumatoid valvular heart disease. Clin Rheumatol. 2006;25(5):743–5.

    Article  PubMed  Google Scholar 

  47. Bourre-Tessier J et al. Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus. 2011;20(14):1518–25.

    Article  CAS  PubMed  Google Scholar 

  48. Leal, G.N., et al., Subclinical left ventricular dysfunction in childhood-onset systemic lupus erythematosus: a two-dimensional speckle-tracking echocardiographic study. Scand J Rheumatol, 2015: p. 1–8.

  49. Foocharoen C et al. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). Rheumatology (Oxford). 2015;54(9):1616–21.

    Article  Google Scholar 

  50. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335(19):1424–30.

    Article  CAS  PubMed  Google Scholar 

  51. Roldan CA et al. Libman-Sacks endocarditis: detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr. 2015;28(7):770–9. This prospective study described the complementary value of 3D transesophageal echocardiography in the detection and characterization of Libman-Sacks endocarditis and the associated clinical manifestations.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Roldan CA. Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis. Minerva Cardioangiol. 2009;57(4):467–81.

    CAS  PubMed  Google Scholar 

  53. Hojnik M et al. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93(8):1579–87.

    Article  CAS  PubMed  Google Scholar 

  54. Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin. 1998;16(3):531–50.

    Article  CAS  PubMed  Google Scholar 

  55. Maksimovic R et al. Cardiac imaging in rheumatic diseases. Rheumatology (Oxford). 2006;45 Suppl 4:iv26–31.

    Google Scholar 

  56. Cauduro SA et al. Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus. Am J Cardiol. 2003;92(11):1370–2.

    Article  PubMed  Google Scholar 

  57. Roldan CA. Valvular and coronary heart disease in systemic inflammatory diseases: systemic disorders in heart disease. Heart. 2008;94(8):1089–101.

    Article  PubMed  Google Scholar 

  58. Hinchcliff M et al. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30(2 Suppl 71):S30–7.

    PubMed  PubMed Central  Google Scholar 

  59. Khanna D et al. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013;65(12):3194–201. This systematic review provided recommendations for the screening and diagnosis of pulmonary hypertension in connective tissue disease.

    Article  PubMed  Google Scholar 

  60. Galie N et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. These are the latest guidelines on the diagnosis and treatment of patients with pulmonary hypertension.

    Article  PubMed  Google Scholar 

  61. Chin K, Mathai SC. Exercise Echocardiography in Connective Tissue Disease. J Am Coll Cardiol. 2015;66(4):385–7.

    Article  PubMed  Google Scholar 

  62. Coghlan JG et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–9. This study proposed a novel, non-invasive evidence-based algorithm for the detection of pulmonary hypertension in systemic sclerosis.

    Article  PubMed  Google Scholar 

  63. Fukuda, Y., et al., Comprehensive Functional Assessment of Right-Sided Heart Using Speckle Tracking Strain for Patients with Pulmonary Hypertension. Echocardiography, 2016.

  64. Kusunose K et al. Prediction of Future Overt Pulmonary Hypertension by 6-Min Walk Stress Echocardiography in Patients With Connective Tissue Disease. J Am Coll Cardiol. 2015;66(4):376–84. This paper described exercise testing using 6 minute walk test in predicting risk of developing pulmonary hypertension in patients with connective tissue disease.

    Article  PubMed  Google Scholar 

  65. Svealv BG et al. Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study. Scand J Rheumatol. 2015;44(2):111–7.

    Article  CAS  PubMed  Google Scholar 

  66. Ustun N et al. Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography. Rheumatol Int. 2015;35(4):607–11.

    Article  PubMed  Google Scholar 

  67. Park SH et al. Early cardiac valvular changes in ankylosing spondylitis: a transesophageal echocardiography study. J Cardiovasc Ultraso. 2012;20(1):30–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kwan-Leung Chan.

Ethics declarations

Conflict of Interest

Maha A. Al-Mohaissen and Kwan-Leung Chan declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Echocardiography

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Mohaissen, M.A., Chan, KL. Echocardiography in the Assessment of Patients with Rheumatologic Diseases. Curr Cardiol Rep 18, 72 (2016). https://doi.org/10.1007/s11886-016-0757-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-016-0757-2

Keywords

Navigation